+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
FEMALE
ID06795893

Pregnancy and Infant Outcomes After Anifrolumab Exposure in Systemic Lupus Erythematosus Using PRIM Data

Led by AstraZeneca · Updated on 2026-09-11

240

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate pregnancy and infant outcomes in women exposed to anifrolumab, a drug used in treating systemic lupus erythematosus SLE. The study collects enhanced data from reported anifrolumab-exposed pregnancies as part of AstraZenecas pharmacovigilance system to better understand the safety of this drug during pregnancy. It focuses on the effects of anifrolumab exposure from 16 weeks before conception through pregnancy and up to 12 months after birth. The program gathers initial pregnancy information from reports submitted by patients or healthcare professionals to AstraZenecas database. Pregnancy outcomes are collected near the time of delivery, with additional follow-up assessments conducted 12 months after birth. For cases where pregnancy outcomes occurred before reporting, retrospective data including pregnancy and infant health details are collected at the time of report. The study uses targeted checklists and guidance to ensure comprehensive and standardized safety data collection for analysis. Participants provide information about their pregnancies and infant health through submitted reports and follow-up contacts. Researchers evaluate major and minor congenital malformations, adverse pregnancy outcomes, and the frequency of these events from conception to 12 months of infant age. The study continues monitoring the collected data until April 2031 to provide ongoing safety information about anifrolumab exposure during pregnancy and its effects on infants.

CONDITIONS

Brief Title

The Anifrolumab PRIM Program

Research Team

A

AstraZeneca Clinical Study Information Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here